High-density in-planta biofortification for sustained GLP-1 metabolic energy

Overview

This patent-pending in-planta biofortification platform engineers plants to synthesize and accumulate biologically active micronutrients directly in edible tissue, creating compact whole-food ingredients with exceptionally high nutrient density. It is designed for people on GLP-1 therapies, who often experience reduced meal volume, digestive side effects from supplements, and chronic fatigue linked to mitochondrial B12 depletion. By delivering active Coenzyme B12 and Provitamin D3 in natural food matrices, the platform supports cellular energy production and bone mineral density during caloric restriction, without requiring the stomach acidity needed to release B12 from animal proteins.

Technical specifications

Key features:

• Engineered genes (Sl7-DR2 and CobA-MetH) introduced via Agrobacterium-based transformation to activate native plant metabolism
• Target delivery per 100 g serving: 18.5 µg Provitamin D3 (100% adult RDA) and 3.5–4.5 µg active Coenzyme B12 (150% adult RDA)
• Active coenzyme form (adenosylcobalamin) directly fuels mitochondrial ATP generation and Krebs-cycle activity
• Compatible with staple crops including tomato, potato, pepper, eggplant, and rice
• Mineral-rich plant matrix avoids synthetic-pill nausea and does not depend on acid-pepsin cleavage for B12 bioavailability
• Can be incorporated into savory purées, compact shots, and functional ingredient bases

Technology readiness level

The technology is at an early-stage laboratory phase, with a phased development roadmap planned. Phase 1 covers synthesis and clonal verification of the two-gene construct; Phase 2 uses transient expression followed by HPLC-DAD and LC-MS quantification to confirm Provitamin D3 and Coenzyme B12 levels; Phase 3 evaluates food-matrix prototypes for nutrient density, shelf stability, and gastrointestinal tolerability; Phase 4 targets commercial licensing and product integration. Key remaining validation steps are analytical confirmation of nutrient content in plant tissue, processing stability, and tolerability in the intended user population.